Mark Zafereo

9.3k total citations · 1 hit paper
192 papers, 4.9k citations indexed

About

Mark Zafereo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Mark Zafereo has authored 192 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Endocrinology, Diabetes and Metabolism, 77 papers in Surgery and 60 papers in Oncology. Recurrent topics in Mark Zafereo's work include Thyroid Cancer Diagnosis and Treatment (95 papers), Head and Neck Cancer Studies (40 papers) and Thyroid and Parathyroid Surgery (31 papers). Mark Zafereo is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (95 papers), Head and Neck Cancer Studies (40 papers) and Thyroid and Parathyroid Surgery (31 papers). Mark Zafereo collaborates with scholars based in United States, United Kingdom and Italy. Mark Zafereo's co-authors include Maria E. Cabanillas, Erich M. Sturgis, Naifa L. Busaidy, Ramona Dadu, Randal S. Weber, Michelle D. Williams, Qingyi Wei, G. Brandon Gunn, Neil D. Gross and Renata Ferrarotto and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mark Zafereo

174 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thyroid Cancer

2024 219 citations Mark Zafereo, Maria E. Cabanillas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Zafereo United States	41	2.1k	1.8k	1.6k	1.2k	942	192	4.9k
Laura D. Locati Italy	38	1.3k 0.6×	2.9k 1.6×	2.8k 1.7×	1.8k 1.5×	1.1k 1.2×	204	6.0k
Amy M. Fremgen United States	28	1.8k 0.8×	2.0k 1.1×	1.7k 1.0×	246 0.2×	1.2k 1.2×	41	4.9k
Jill Gilbert United States	33	428 0.2×	1.1k 0.6×	2.1k 1.3×	1.3k 1.1×	1.2k 1.3×	91	4.5k
Daniel W. Bowles United States	30	597 0.3×	782 0.4×	1.4k 0.9×	428 0.3×	872 0.9×	117	3.1k
Yuuki Takamura Japan	43	5.5k 2.6×	4.0k 2.2×	977 0.6×	88 0.1×	300 0.3×	130	7.1k
Mira Milas United States	36	1.1k 0.5×	1.7k 0.9×	955 0.6×	55 0.0×	799 0.8×	95	3.5k
Chisato Tomoda Japan	36	3.9k 1.8×	2.7k 1.5×	654 0.4×	59 0.0×	378 0.4×	110	4.9k
W. David J. Ryder United Kingdom	30	538 0.3×	731 0.4×	1.3k 0.8×	93 0.1×	995 1.1×	64	3.1k
Alexandre Bozec France	29	216 0.1×	1.1k 0.6×	845 0.5×	867 0.7×	833 0.9×	158	2.9k
Akihiro Miya Japan	51	8.6k 4.1×	5.8k 3.3×	1.4k 0.9×	104 0.1×	517 0.5×	252	10.5k

Countries citing papers authored by Mark Zafereo

Since Specialization

Citations

This map shows the geographic impact of Mark Zafereo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Zafereo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Zafereo more than expected).

Fields of papers citing papers by Mark Zafereo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Zafereo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Zafereo. The network helps show where Mark Zafereo may publish in the future.

Co-authorship network of co-authors of Mark Zafereo

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Zafereo. A scholar is included among the top collaborators of Mark Zafereo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Zafereo. Mark Zafereo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cabanillas, Maria E., Naifa L. Busaidy, G. Brandon Gunn, et al.. (2025). Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer. Thyroid. 35(7). 763–770. 1 indexed citations

Coca‐Pelaz, Andrés, Juan P. Rodrigo, Abbas Agaimy, et al.. (2024). Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): what do we need to know?. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(6). 977–987. 2 indexed citations

Learned, Kim O., Jennifer Wang, Xiao Zhao, et al.. (2024). [¹⁸F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma followingBRAF-Targeted Therapy. American Journal of Neuroradiology. 46(6). 1260–1267.

Hu, Mimi I., Roland L. Bassett, Anita K. Ying, et al.. (2024). Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades. The Journal of Clinical Endocrinology & Metabolism. 109(9). 2256–2268. 8 indexed citations

Hu, Mimi I., Yi‐Ju Chiang, Paul H. Graham, et al.. (2024). Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness. Journal of the Endocrine Society. 8(6). bvae048–bvae048. 8 indexed citations

Mulder, Michelle B., Hui Zhao, Kelly W. Merriman, et al.. (2024). The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?. Thyroid. 34(9). 1117–1125. 1 indexed citations

Piazza, Cesare, Davide Lancini, Michele Tomasoni, et al.. (2024). Malignant carotid body tumors: What we know, what we do, and what we need to achieve. A systematic review of the literature. Head & Neck. 46(3). 672–687. 2 indexed citations

Czarnywojtek, Agata, Lester D.�R. Thompson, Asterios Triantafyllou, et al.. (2023). IgG4-related sclerosing thyroiditis (Riedel-Struma): a review of clinicopathological features and management. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(2). 133–144. 7 indexed citations

Sanabria, Álvaro, Carlos M. Chiesa‐Estomba, Andrés Coca‐Pelaz, et al.. (2023). Locoregional strategies to decrease postoperative pain and neck discomfort after open thyroidectomy: A scoping review. Head & Neck. 45(7). 1841–1855. 5 indexed citations

10.

Rao, Karthik, Ripu Daman Arora, Nitin M. Nagarkar, et al.. (2023). A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers. Oncology and Therapy. 11(4). 461–480. 8 indexed citations

11.

Wang, Jennifer, Xu Li, Maitrayee Goswami, et al.. (2022). Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO Precision Oncology. 6(6). e2100504–e2100504. 45 indexed citations

12.

Hoffman, Aubri, Maria E. Cabanillas, Julie Ann Sosa, et al.. (2021). Decision Making When Cancer Becomes Chronic: Needs Assessment for a Web-Based Medullary Thyroid Carcinoma Patient Decision Aid. JMIR Formative Research. 5(7). e27484–e27484. 5 indexed citations

13.

Sanabria, Álvaro, Renan Bezerra Lira, Jatin P. Shah, et al.. (2021). Current therapeutic options for low‐risk papillary thyroid carcinoma: Scoping evidence review. Head & Neck. 44(1). 226–237. 9 indexed citations

14.

Boukovalas, Stefanos, Ryan P. Goepfert, Jeffrey M. Smith, et al.. (2020). Association between postoperative complications and long‐term oncologic outcomes following total laryngectomy: 10‐year experience at MD Anderson Cancer Center. Cancer. 126(22). 4905–4916. 13 indexed citations

15.

Debnam, J. Matthew, Nandita Guha‐Thakurta, Jia Sun, et al.. (2020). Distinguishing Recurrent Thyroid Cancer from Residual Nonmalignant Thyroid Tissue Using Multiphasic Multidetector CT. American Journal of Neuroradiology. 41(5). 844–851. 5 indexed citations

16.

Ronen, Ohad, K. Thomas Robbins, Kerry D. Olsen, et al.. (2020). Case for staged thyroidectomy. Head & Neck. 42(10). 3061–3071. 11 indexed citations

17.

Bossi, Paolo, Salvatore Alfieri, Primož Strojan, et al.. (2019). Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature. Critical Reviews in Oncology/Hematology. 137. 84–91. 45 indexed citations

18.

Filho, João Gonçalves, Mark Zafereo, Faisal I. Ahmad, et al.. (2018). Decision making for the central compartment in differentiated thyroid cancer. European Journal of Surgical Oncology. 44(11). 1671–1678. 18 indexed citations

19.

Goepfert, Ryan P., Katherine A. Hutcheson, Jan S. Lewin, et al.. (2016). Complications, hospital length of stay, and readmission after total laryngectomy. Cancer. 123(10). 1760–1767. 71 indexed citations

20.

Mitani, Yoshitsugu, Bin Liu, Pulivarthi H. Rao, et al.. (2015). Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clinical Cancer Research. 22(3). 725–733. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact